The definition of Systemic Lupus Erythematosus (SLE) related arthritis have been substantially changed due to the application of more sensitive imaging techniques. Thus, erosive arthritis could be identified in 40% of patients, suggesting the need for specific biomarkers. In this view, ACPA and anti-CarP have been associated with erosive damage; furthermore, the role of Dkk-1 was suggested. We used Cluster Analysis (CA) to identify different clinical and laboratory features associated with erosive arthritis.
We enrolled patients with a clinical history of joint involvement, evaluating the presence of erosive arthritis by hands ultrasound. Clinical and laboratory data were collected, including Rheumatoid Factor (RF), ACPA, anti-CarP, Dkk-1 levels. An unsupervised hierarchical CA was performed (SPSS 26 version) to identify the aggregation of patients into different subgroups sharing common features.
One hundred twelve patients (M/F 6/106; median age 45 years, IQR 17; median disease duration 96 months, IQR 165) were analyzed. Erosive arthritis was identified in 25.9% of patients; RF was positive in 31.2% of patients, anti-CarP in 23.2%, ACPA in 8%, detectable Dkk-1 in 6.2%. CA for clinical characteristics identified four defined clusters (figure 1). Interestingly, in the same cluster were allocated ACPA and anti-CarP positivity, detectable Dkk-1 levels, erosive arthritis and renal manifestations. RF resulted allocated in a different cluster, including anti-SSA and anti-SSB.
CA identified a specific SLE phenotype with erosive arthritis, renal manifestations, anti-CarP and ACPA positivity and detectable Dkk-1. We could speculate about the presence of a shared pathogenic mechanism, involving NETosis, contributing to nephritis and erosive arthritis.